The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Exciting Partnerships Forming Between Big Pharma and Tech
January 29th 2018Lean, private firms being acquired by big pharma is not necessarily a new trend. But, with excitement in the health care technology space and established tech firms attempting to enter that market, partnerships are taking a new perspective to cut costs and increase quality.
Read More